Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast cancer and glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Glioblastoma
• Head and Neck Squamous Cell Carcinoma
• Malignant Mesothelioma
• Non-small Cell Lung Cancer
• Sarcoma

Drugs mentioned

• PRT3645

Snippet

Sponsor: Prelude Therapeutics | Conditions: Breast Cancer, Glioblastoma | Phase 1 | Status: COMPLETED